These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34609121)

  • 21. Is the METS-IR Index a Potential New Biomarker for Kidney Stone Development?
    Shen X; Chen Y; Chen Y; Liang H; Li G; Hao Z
    Front Endocrinol (Lausanne); 2022; 13():914812. PubMed ID: 35909543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis.
    Trinchieri A; Croppi E; Simonelli G; Sciorio C; Montanari E
    Urolithiasis; 2020 Apr; 48(2):123-129. PubMed ID: 31037403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and stones.
    Sarica K
    Curr Opin Urol; 2019 Jan; 29(1):27-32. PubMed ID: 30308572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney stones: Composition, frequency and relation to metabolic diagnosis.
    Spivacow FR; Del Valle EE; Lores E; Rey PG
    Medicina (B Aires); 2016; 76(6):343-348. PubMed ID: 27959841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994.
    West B; Luke A; Durazo-Arvizu RA; Cao G; Shoham D; Kramer H
    Am J Kidney Dis; 2008 May; 51(5):741-7. PubMed ID: 18436084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney stones: a fetal origins hypothesis.
    Howles SA; Edwards MH; Cooper C; Thakker RV
    J Bone Miner Res; 2013 Dec; 28(12):2535-9. PubMed ID: 23703881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The growing prevalence of kidney stones and opportunities for prevention.
    Richman K; O'Bell J; Pareek G
    R I Med J (2013); 2014 Dec; 97(12):31-4. PubMed ID: 25463625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and lifestyle-associated risk factors of metabolic syndrome among commercial motor vehicle drivers in a metropolitan city in Ghana.
    Appiah CA; Afriyie EO; Hayford FEA; Frimpong E
    Pan Afr Med J; 2020; 36():136. PubMed ID: 32849991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between metabolic syndrome and the presence of kidney stones in a screened population.
    Jeong IG; Kang T; Bang JK; Park J; Kim W; Hwang SS; Kim HK; Park HK
    Am J Kidney Dis; 2011 Sep; 58(3):383-8. PubMed ID: 21620546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life.
    Lim JRZ; Scotland KB; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Bird VG; Andonian S; Bhojani N; Canvasser NE; Harper JD; Penniston KL; Chew BH
    J Endourol; 2020 Nov; 34(11):1203-1208. PubMed ID: 32689819
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence.
    Rendina D; De Filippo G; D'Elia L; Strazzullo P
    J Nephrol; 2014 Aug; 27(4):371-6. PubMed ID: 24696310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal stone disease and obesity: what is important for urologists and nephrologists?
    Ahmed MH; Ahmed HT; Khalil AA
    Ren Fail; 2012; 34(10):1348-54. PubMed ID: 23013150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid nephrolithiasis: An update.
    Cicerello E
    Urologia; 2018 Aug; 85(3):93-98. PubMed ID: 29687761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of hypertension in the metabolic syndrome: who is affected?
    Velarde G; Berk BC
    Curr Hypertens Rep; 2005 Dec; 7(6):418-26. PubMed ID: 16386197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Metabolic Syndrome Among Mexican Adults.
    Ortiz-Rodríguez MA; Bautista-Ortiz LF; Villa AR; Antúnez-Bautista PK; Aldaz-Rodríguez MV; Estrada-Luna D; Denova-Gutiérrez E; Camacho-Díaz BH; Martínez-Salazar MF
    Metab Syndr Relat Disord; 2022 Jun; 20(5):264-272. PubMed ID: 35325577
    [No Abstract]   [Full Text] [Related]  

  • 38. [Incidence of metabolic syndrome and associated lifestyle factors in a worksite male population].
    Otsuka T; Kawada T; Yanai M; Kitagawa Y; Kan H
    Sangyo Eiseigaku Zasshi; 2011; 53(3):78-86. PubMed ID: 21372516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?
    DiBianco JM; Jarrett TW; Mufarrij P
    Rev Urol; 2015; 17(3):117-28. PubMed ID: 26543426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.
    Ma AR; Liu F; Wang R; Lin L; Wang Y; Li Q; Lu X; Du J
    Front Endocrinol (Lausanne); 2021; 12():677912. PubMed ID: 34970217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.